Stock Events

Stock Events

Xeris Biopharma (2B30.F) Q4 2023 Earnings

Mar 6Confirmed

Q4 2023

-0.09

-0.09

-0.08

-0.08

Details

Expected EPS

-0.07843286304

Actual EPS

-0.091744

Surprise EPS

-0.01

Surprise Percent

-16.97%

Description

⁨Xeris Biopharma⁩ (⁦2B30.F⁩) has reported earnings of ⁦-0.091744⁩ per share for ⁦Q4 2023⁩.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.